Block Arcade, 96 Elizabeth St.
Level 3 Office 324
Melbourne, VIC 3000
Australia
61 2 8072 1400
https://www.scu.com.sg
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Matthew Robert Leonard | MD & Executive Director | 71,97k | N/D | N/D |
Mr. Chow-Yee Koh | Chief Financial Officer | 138,7k | N/D | 1976 |
Mr. Francesco Cannavo | Part-Time Executive Director | 117,6k | N/D | N/D |
Mr. Justyn Peter Stedwell B.Com, B.Com. | Company Secretary | N/D | N/D | 1981 |
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
L'ISS Governance QualityScore di BPH Global Ltd al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.